Andrey Gurevich - Concepedia

Author

Andrey Gurevich

Also Known As

A. J. Gurevich, Andrey Gurevich, Andrey K. Gurevich, Esther Zumsteg, Gurevich, Andrey

Publications

351

Citations

H-Index

Concepts

All Affiliations

Andrey Gurevich is an author at Takeda (Switzerland) specializing in medicine, biostatistics, and pathology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	13
2	Public Health	1	1	13
3	Biostatistics	1	1	13
4	Pathology	1	1	13
5	Pharmacology	1	1	13

Andrey Gurevich

Publications

260

Citations

H-Index

Page 1

	Year	Citations
Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery Aliya Khan, John P. Bilezikian, Henry G. Bone, European Journal of Endocrinology	2015	79
<p>Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age</p> Rossella Parini, Guillem Pintos‐Morell, Julia B. Hennermann, Drug Design Development and Therapy	2020	49
Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis Derralynn Hughes, Aleš Linhart, Andrey Gurevich, Drug Design Development and Therapy	2021	45
Urinary Concentrating Defect in Hypothyroid Rats Melissa A. Cadnapaphornchai, Yang-Wook Kim, Andrey Gurevich, Journal of the American Society of Nephrology	2003	44
Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study Sandro Feriozzi, Aleš Linhart, Uma Ramaswami, Clinical Therapeutics	2020	30
Inter-assay variability influences migalastat amenability assessments among Fabry disease variants Susan Oommen, Yanfeng Zhou, M. Muthuraman, Molecular Genetics and Metabolism Fabry DiseaseMendelian DisorderMedicineGeneticsIga Glomerulonephritis	2019	13

Page 1